Current Edition


Beyond Pill Count: Challenging the Status Quo for Medication Adherence in Clinical Trials

Poor adherence to the investigational product can bring even the most carefully planned clinical trial to its knees. It is time to accept that traditional …

Continue Reading →

NIH-funded researchers present preliminary clinical trial results suggesting aggressive blood pressure control may lower risk of cognitive impairment

What Preliminary findings from a large clinical trial, the Systolic Blood Pressure Intervention Trial (SPRINT) Memory and Cognition IN Decreased Hypertension (SPRINT MIND) study will …

Continue Reading →

Researchers Develop Diagnostic for Rare Cancer-Generated Glycoproteins

Engineered chemical trap detects rare glycoproteins emitted as cancer first develops. Researchers at the Georgia Institute of Technology have designed a boronic acid derivative that …

Continue Reading →

US researchers develop tool to improve diagnostic accuracy

The tool has been used to analyse protein variation in diabetes, cancer, cardiovascular disease, neuro and retinal degeneration. A research team at the University at …

Continue Reading →

Failing to adopt the EU’s Clinical Trials Regulation risks leaving researchers in the UK out in the cold

As the House of Lords today debate an amendment to the EU (Withdrawal) Bill, some of the UK’s biggest research organisations –including the British Heart …

Continue Reading →